Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | JAK2 | O60674 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | GMNN | O75496 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL9162098 | 0.92 | GAA (0.41) | CA2TP53TSHRCA1GAA | |
| Phenol SCHEMBL6858850 | 0.92 | CA2 (0.41) | CA2TP53TSHRCA1GAA | |
| SCHEMBL4636948 | 0.85 | CA2 (0.35) | CA2TP53TSHRCA1GAA | |
| SCHEMBL28459068 | 0.84 | CA1 (0.55) | CA2TP53TSHRCA1LMNA | |
| 4-Vinylphenol SCHEMBL4451040 | 0.82 | TRPA1 (0.37) | CA2TP53TSHRCA1GAA | |
| 2-Allylphenol SCHEMBL4453155 | 0.81 | GABRA1 (0.38) | TSHRGAALMNAMAPTJAK2 | |
| Chavicol SCHEMBL4444837 | 0.79 | ALDH1A1 (0.41) | CA2TP53TSHRCA1GAA | |
| SCHEMBL4449489 | 0.77 | GAA (0.39) | CA2TSHRCA1GAALMNA | |
| SCHEMBL9775497 | 0.77 | LMNA (0.45) | CA2TP53TSHRCA1GAA | |
| SCHEMBL170029 | 0.73 | LMNA (0.41) | CA2TP53TSHRCA1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112824450-A | Low-temperature-resistant high-fluidity flame-retardant PC | 广东新通彩材料科技有限公司 | 2021-05-21 | — | — | CN | claimed |
| EP-2691461-B1 | ELECTRICAL TRACKING RESISTANCE COMPOSITIONS, METHODS&ARTICLES OF MANUFACTURE | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2017-11-22 | — | — | EP | claimed |
| EP-2691460-B1 | ELECTRICAL TRACKING RESISTANCE COMPOSITIONS, METHODS&ARTICLES OF MANUFACTURE | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2017-08-02 | — | — | EP | claimed |
| EP-2691473-B1 | FLAME RETARDANT POLYCARBONATE COMPOSITIONS, METHODS OF MANUFACTURE, AND ARTICLES FORMED THEREFROM | SABIC INNOVATIVE PLASTICS IP (NL) | 2015-04-22 | — | — | EP | claimed |
| EP-1530606-B1 | SILOXANE BISCHLOROFORMATES | SABIC INNOVATIVE PLASTICS IP (NL) | 2010-12-08 | — | — | EP | claimed |
| EP-1937693-A1 | SILOXANE BISCHLOROFORMATES | General Electric Company (US) | 2008-07-02 | — | — | EP | claimed |
| CN-1324071-C | Siloxane bischloroformates | GEN ELECTRIC (US) | 2007-07-04 | — | — | CN | claimed |
| US-20070093629-A1 | Siloxane bishchloroformates | GENERAL ELECTRIC COMPANY (US) | 2007-04-26 | — | — | US | claimed |
| WO-2007037888-A1 | SILOXANE BISCHLOROFORMATES | GENERAL ELECTRIC COMPANY (US) | 2007-04-05 | — | — | WO | claimed |
| CN-1688634-A | Siloxane bischloroformates | GEN ELECTRIC (US) | 2005-10-26 | — | — | CN | claimed |
| EP-1530606-A1 | SILOXANE BISCHLOROFORMATES | GENERAL ELECTRIC COMPANY (US) | 2005-05-18 | — | — | EP | claimed |
| US-20040133024-A1 | Siloxane bischloroformates | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2004-07-08 | — | — | US | claimed |
| US-6723864-B2 | CONTINUOUS PROCESS BY PHOSGENATING SILOXANE BISPHENOLS IN A FLOW REACTOR USING A SUBSTANTIAL EXCESS OF PHOSGENE AND SODIUM HYDROXIDE | GENERAL ELECTRIC COMPANY | 2004-04-20 | — | — | US | claimed |
| WO-2004016675-A1 | SILOXANE BISCHLOROFORMATES | GENERAL ELECTRIC COMPANY (US) | 2004-02-26 | — | — | WO | claimed |
| US-20040039218-A1 | A continuous process by phosgenating siloxane bisphenols in a flow reactor using a substantial excess of phosgene and sodium hydroxide to achieve high yields and very pure product; intermediates for polycarbonatesiloxanes | GENERAL ELECTRIC COMPANY | 2004-02-26 | — | — | US | claimed |
| US-4478981-A | CONTACT LENSES | PETRARCH SYSTEMS INC. (US) | 1984-10-23 | — | — | US | claimed |
| EP-4288482-B1 | LINEAR BLOCK COPOLYMER TOUGHENER WITH ACRYLATE FUNCTIONAL GROUPS | ELE CORP (US) | 2025-07-30 | — | — | EP | disclosed |
| US-12122881-B2 | Linear block copolymer toughener with acrylate functional groups | ELE' CORPORATION (US) | 2024-10-22 | — | — | US | disclosed |
| EP-0298279-A2 | Electrostatographic toner and developer compositions | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1989-01-11 | — | — | EP | disclosed |
| US-4758491-A | Dry toner and developer composition | EASTMAN KODAK COMPANY (US) | 1988-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040133024-A1 | Siloxane bischloroformates | PSMA2, PSMA3, PSMA4 | CA2 1199/4885TP53 902/4885TSHR 4080/4885 |
| US-20040039218-A1 | A continuous process by phosgenating siloxane bisphenols in a flow reactor using a substantial excess of phosgene and sodium hydroxide to achieve high yields and very pure product; intermediates for polycarbonatesiloxanes | PSPH, PAH, SEM1 | CA2 626/4885TP53 1259/4885TSHR 4127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.